Europe · Markets & Finance · BFM Business

"Un pôle d'innovation essentiel": Bayer va investir 2,2 milliards de dollars dans un site pharmaceutique aux États-Unis

Published by BFM Business · France 1 h ago

Le futur site de Bayer, dans l'Ohio, travaillera sur les produits pharmaceutiques destinés au traitement du cancer, des maladies cardiaques et rénales. Il s'agit d'un…

Read the full article on BFM Business Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.bfmtv.com)

Also worth reading

Financial Times

China launches anti-dumping probe into European chemical exports

This is Money

Our neighbour's broken wall is pushing over our garden fence, but she refuses to repair it. What can we do?

City A.M.

Is Soho nightlife really dead? We went partying to find out

Reuters Markets

Japan shifts messaging to counter view its policies are reflationary, Katayama says in TV interview

MoneyWeek

8 of the best houses for sale with stables

Reuters Sustainability